In colorectal cancer, higher β-catenin levels led to an inhibition of CCL4, a proinflammatory chemokine, and subsequently lower recruitment of CD103+ DCs thus impairing CD8+ T cell activation (27, 51, 52). This evidence concerns the gene CCL4 and colorectal cancer.